Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
SN6 SHORT NOTE 5M ★ High-yield

Describe the inhalational devices and the inhaled corticosteroids.

Pharmacology · 2nd Professional — Para-Clinical

WHY the Device Matters as Much as the Drug

  • Only about 10 to 20% of an inhaled dose reaches the lung even with perfect technique; most is swallowed or deposited in the oropharynx
  • Poor technique is extremely common — studies consistently find that most patients, and many prescribers, make at least one critical error. It is the single commonest reason inhaled treatment "fails"
  • Inhaled delivery achieves high airway concentrations with low systemic exposure, which is why inhaled corticosteroids can be given for years while oral steroids cannot

Types of Device

DeviceHow it worksAdvantagesLimitations
Pressurised metered-dose inhaler (pMDI)Propellant delivers a fixed dose; requires slow deep inhalation coordinated with actuationCheap, portable, multi-doseCoordination is difficult, particularly for children and the elderly; high oropharyngeal deposition
PMDI with a spacerThe chamber holds the aerosol, allowing tidal breathing and removing the need for coordinationGreatly improves lung deposition; reduces oropharyngeal candidiasis and dysphonia; as effective as a nebuliser in most acute attacksBulky; needs regular washing and air-drying (not wiping, which creates static)
Dry powder inhaler (DPI)Breath-actuated; requires a forceful deep inspiration to disaggregate the powderNo coordination needed; no propellantUseless if inspiratory flow is inadequate — young children, the frail, and patients in a severe attack
Breath-actuated pMDIFires on inspirationRemoves the coordination problemMore expensive
NebuliserConverts solution to a mist inhaled by tidal breathingNeeds no cooperation; for the very young, very ill or very breathlessSlow, bulky, needs a power source; no better than a pMDI with spacer in most acute asthma; risk of infection from poorly cleaned equipment

CLINICAL PEARL

A spacer converts a difficult device into an easy one, and its benefits go beyond convenience. It removes the coordination problem, slows the aerosol so that less impacts on the throat. It reduces oral candidiasis and dysphonia, and at the same time increases lung deposition. In acute asthma, a pMDI with a spacer performs as well as a nebuliser for most patients, is faster, cheaper and carries no infection risk — and in a child a spacer with a face mask is the standard of care.

Inhaled Corticosteroids

  • Drugs — budesonide, fluticasone, beclometasone, ciclesonide (a prodrug activated in the lung, which reduces oropharyngeal effects), mometasone
  • The cornerstone of asthma control — the only class that treats the underlying inflammation, and the only one shown to reduce asthma deaths
  • Local adverse effects — oropharyngeal candidiasis, dysphonia (hoarseness from laryngeal myopathy), cough and throat irritation; all reduced by a spacer and by rinsing and spitting after use
  • Systemic effects, chiefly at high dose — adrenal suppression, reduced growth velocity in children (a small effect, largely recovered in final height), reduced bone density, cataract, glaucoma, skin thinning and easy bruising
  • In COPD they increase the risk of pneumonia, which is why they are reserved for those with frequent exacerbations or eosinophilia rather than given to everyone

Applied Aspects

  • Watch the patient use their inhaler at every review, and correct the technique; do not ask whether they can use it, since almost everyone says yes
  • Match the device to the patient — a dry powder inhaler is useless in a frail elderly patient with poor inspiratory flow, and a plain pMDI is useless in a child without a spacer
  • Prescribe a spacer with every pMDI corticosteroid, and teach washing in detergent and air-drying
  • Teach mouth rinsing after every corticosteroid dose — it prevents candidiasis and dysphonia and takes seconds
  • Avoid changing device type without retraining; a switch made for cost reasons without teaching commonly causes deterioration
  • Cost and availability shape practice in India — a pMDI with a home-made spacer (a modified plastic bottle has been shown to work well) is an effective and affordable option where commercial spacers are out of reach
  • Check the counter or float the canister to confirm the inhaler is not empty; patients frequently continue using a spent device and conclude their asthma has worsened

All questions in Gastrointestinal & Respiratory Drugs

  1. Q1Describe the physiology of gastric acid secretion. Classify the drugs used in peptic ulcer and reflux disease with their uses and adverse effects. ★
  2. Q2Describe the physiology of vomiting. Classify antiemetics and describe the choice of drug in different situations. ★
  3. Q3Classify laxatives and antidiarrhoeal drugs. Describe the drugs used in inflammatory bowel disease. ★
  4. Q4Classify the drugs used in bronchial asthma. Describe the stepwise management of chronic asthma and of acute severe asthma. ★
  5. Q5Describe the drugs used in COPD and cough. Describe the methylxanthines with their interactions and toxicity. ★
  6. SN1Describe the proton pump inhibitors with their mechanism, uses and adverse effects. ★
  7. SN2Describe the regimens used for Helicobacter pylori eradication and the principles of testing. ★
  8. SN3Describe the antiemetics used in chemotherapy-induced nausea and vomiting. ★
  9. SN4Describe the scientific basis, composition and use of oral rehydration therapy. ★
  10. SN5Describe theophylline with its mechanism, interactions, toxicity and place in therapy. ★
  11. SN6Describe the inhalational devices and the inhaled corticosteroids. ★
  12. SN7Describe the drugs used in hepatic encephalopathy and the principles of prescribing in chronic liver disease.

Every Pharmacology chapter →

Scroll to Top